annual operating expenses:
$33.86B+$5.04B(+17.49%)Summary
- As of today (May 29, 2025), AZN annual total operating expenses is $33.86 billion, with the most recent change of +$5.04 billion (+17.49%) on December 31, 2024.
- During the last 3 years, AZN annual operating expenses has risen by +$8.74 billion (+34.81%).
- AZN annual operating expenses is now at all-time high.
Performance
AZN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$7.67B-$2.46B(-24.25%)Summary
- As of today (May 29, 2025), AZN quarterly total operating expenses is $7.67 billion, with the most recent change of -$2.46 billion (-24.25%) on March 31, 2025.
- Over the past year, AZN quarterly operating expenses has increased by +$327.00 million (+4.45%).
- AZN quarterly operating expenses is now -24.25% below its all-time high of $10.13 billion, reached on December 31, 2024.
Performance
AZN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AZN Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +17.5% | +4.5% |
3 y3 years | +34.8% | +9.6% |
5 y5 years | +91.0% | +106.6% |
AZN Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +34.8% | -24.3% | +19.9% |
5 y | 5-year | at high | +94.6% | -24.3% | +115.5% |
alltime | all time | at high | +565.3% | -24.3% | +1011.4% |
AZN Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $7.67B(-24.3%) |
Dec 2024 | $33.86B(+17.5%) | $10.13B(+20.9%) |
Sep 2024 | - | $8.38B(+4.6%) |
Jun 2024 | - | $8.01B(+9.0%) |
Mar 2024 | - | $7.35B(-13.4%) |
Dec 2023 | $28.82B(+5.0%) | $8.48B(+14.0%) |
Sep 2023 | - | $7.44B(+6.3%) |
Jun 2023 | - | $7.00B(+5.0%) |
Mar 2023 | - | $6.67B(+4.2%) |
Dec 2022 | $27.45B(+9.3%) | $6.40B(-5.3%) |
Sep 2022 | - | $6.75B(-6.6%) |
Jun 2022 | - | $7.23B(+3.3%) |
Mar 2022 | - | $7.00B(-21.1%) |
Dec 2021 | $25.12B(+44.3%) | $8.87B(+14.0%) |
Sep 2021 | - | $7.78B(+58.8%) |
Jun 2021 | - | $4.90B(+37.7%) |
Mar 2021 | - | $3.56B(-36.9%) |
Dec 2020 | $17.40B(-1.8%) | $5.64B(+39.8%) |
Sep 2020 | - | $4.04B(+0.7%) |
Jun 2020 | - | $4.01B(+7.9%) |
Mar 2020 | - | $3.71B(-37.0%) |
Dec 2019 | $17.73B(+6.5%) | $5.89B(+37.2%) |
Sep 2019 | - | $4.30B(+0.7%) |
Jun 2019 | - | $4.27B(+30.7%) |
Mar 2019 | - | $3.27B(-51.8%) |
Dec 2018 | $16.64B(+3.4%) | $6.77B(+106.7%) |
Sep 2018 | - | $3.27B(-3.1%) |
Jun 2018 | - | $3.38B(+1.0%) |
Mar 2018 | - | $3.35B(-30.7%) |
Dec 2017 | $16.09B(+5.2%) | $4.83B(+26.1%) |
Sep 2017 | - | $3.83B(+20.7%) |
Jun 2017 | - | $3.18B(-11.6%) |
Mar 2017 | - | $3.59B(+83.5%) |
Dec 2016 | $15.30B(-9.9%) | $1.96B(-48.1%) |
Sep 2016 | - | $3.77B(-11.0%) |
Jun 2016 | - | $4.24B(+4.1%) |
Mar 2016 | - | $4.07B(-20.0%) |
Dec 2015 | $17.00B(-7.2%) | $5.09B(+36.3%) |
Sep 2015 | - | $3.73B(-13.5%) |
Jun 2015 | - | $4.32B(+12.0%) |
Mar 2015 | - | $3.85B(-16.5%) |
Dec 2014 | $18.32B(+8.7%) | $4.62B(-0.8%) |
Sep 2014 | - | $4.65B(+7.1%) |
Jun 2014 | - | $4.35B(+4.2%) |
Mar 2014 | - | $4.17B(-31.7%) |
Dec 2013 | $16.85B(+14.6%) | $6.10B(+84.6%) |
Sep 2013 | - | $3.31B(-11.0%) |
Jun 2013 | - | $3.71B(-0.2%) |
Mar 2013 | - | $3.72B(-11.0%) |
Dec 2012 | $14.70B(-9.8%) | $4.18B(+28.6%) |
Sep 2012 | - | $3.25B(-5.6%) |
Jun 2012 | - | $3.45B(-9.6%) |
Mar 2012 | - | $3.81B(-40.3%) |
Dec 2011 | $16.29B(+6.3%) | $6.39B(+171.1%) |
Sep 2011 | - | $2.36B(-40.8%) |
Jun 2011 | - | $3.98B(+12.1%) |
Mar 2011 | - | $3.55B(-19.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $15.33B(-4.4%) | $4.39B(+10.6%) |
Sep 2010 | - | $3.97B(+7.5%) |
Jun 2010 | - | $3.69B(+12.6%) |
Mar 2010 | - | $3.28B(-40.5%) |
Dec 2009 | $16.04B(+1.1%) | $5.51B(+47.5%) |
Sep 2009 | - | $3.73B(+2.5%) |
Jun 2009 | - | $3.64B(+15.5%) |
Mar 2009 | - | $3.15B(-29.0%) |
Dec 2008 | $15.86B(+5.4%) | $4.45B(+21.5%) |
Sep 2008 | - | $3.66B(-6.7%) |
Jun 2008 | - | $3.92B(+2.3%) |
Mar 2008 | - | $3.83B(-18.5%) |
Dec 2007 | $15.05B(+18.5%) | $4.70B(+31.5%) |
Sep 2007 | - | $3.58B(+3.5%) |
Jun 2007 | - | $3.46B(+4.4%) |
Mar 2007 | - | $3.31B(-7.4%) |
Dec 2006 | $12.70B(+5.0%) | $3.57B(+16.3%) |
Sep 2006 | - | $3.07B(-2.7%) |
Jun 2006 | - | $3.16B(+8.9%) |
Mar 2006 | - | $2.90B(-11.1%) |
Dec 2005 | $12.09B(+3.5%) | $3.26B(+14.5%) |
Sep 2005 | - | $2.85B(-8.1%) |
Jun 2005 | - | $3.10B(+7.7%) |
Mar 2005 | - | $2.88B(-5.0%) |
Dec 2004 | $11.69B(+12.6%) | $3.03B(+7.9%) |
Sep 2004 | - | $2.81B(-6.0%) |
Jun 2004 | - | $2.98B(+4.2%) |
Mar 2004 | - | $2.86B(-7.0%) |
Dec 2003 | $10.38B(+11.4%) | $3.08B(+22.5%) |
Sep 2003 | - | $2.51B(+2.4%) |
Jun 2003 | - | $2.45B(+5.3%) |
Mar 2003 | - | $2.33B(-20.6%) |
Dec 2002 | $9.31B(+18.4%) | $2.94B(+31.5%) |
Sep 2002 | - | $2.23B(+2.1%) |
Jun 2002 | - | $2.19B(+11.9%) |
Mar 2002 | - | $1.96B(-8.8%) |
Dec 2001 | $7.87B(-42.3%) | $2.14B(+14.6%) |
Sep 2001 | - | $1.87B(-8.6%) |
Jun 2001 | - | $2.05B(+8.8%) |
Mar 2001 | - | $1.88B(-76.0%) |
Dec 2000 | $13.64B(+61.3%) | $7.83B(+311.9%) |
Sep 2000 | - | $1.90B(-4.4%) |
Jun 2000 | - | $1.99B(+3.3%) |
Mar 2000 | - | $1.92B(+11.4%) |
Dec 1999 | $8.46B(+23.3%) | $1.73B(-18.4%) |
Sep 1999 | - | $2.12B(-8.1%) |
Jun 1999 | - | $2.31B(+37.2%) |
Dec 1998 | $6.86B(+1.3%) | - |
Jun 1998 | - | $1.68B(+143.3%) |
Dec 1997 | $6.77B(-7.4%) | - |
Dec 1996 | $7.32B(+24.3%) | - |
Dec 1995 | $5.89B(+1.3%) | - |
Jun 1995 | - | $690.40M |
Dec 1994 | $5.81B(+4.7%) | - |
Dec 1993 | $5.55B(+9.0%) | - |
Dec 1992 | $5.09B(-16.3%) | - |
Dec 1991 | $6.08B(+0.7%) | - |
Dec 1990 | $6.04B | - |
FAQ
- What is AstraZeneca annual total operating expenses?
- What is the all time high annual operating expenses for AstraZeneca?
- What is AstraZeneca annual operating expenses year-on-year change?
- What is AstraZeneca quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AstraZeneca?
- What is AstraZeneca quarterly operating expenses year-on-year change?
What is AstraZeneca annual total operating expenses?
The current annual operating expenses of AZN is $33.86B
What is the all time high annual operating expenses for AstraZeneca?
AstraZeneca all-time high annual total operating expenses is $33.86B
What is AstraZeneca annual operating expenses year-on-year change?
Over the past year, AZN annual total operating expenses has changed by +$5.04B (+17.49%)
What is AstraZeneca quarterly total operating expenses?
The current quarterly operating expenses of AZN is $7.67B
What is the all time high quarterly operating expenses for AstraZeneca?
AstraZeneca all-time high quarterly total operating expenses is $10.13B
What is AstraZeneca quarterly operating expenses year-on-year change?
Over the past year, AZN quarterly total operating expenses has changed by +$327.00M (+4.45%)